2017
DOI: 10.1016/s1473-3099(16)30533-3
|View full text |Cite|
|
Sign up to set email alerts
|

Helminths in organ transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
13
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(13 citation statements)
references
References 135 publications
0
13
0
Order By: Relevance
“…Infection occurs when humans come into contact with soil that is contaminated with filariform larvae, which then penetrate the skin and enter the lymphatic system. Infection with this organism is particularly dangerous for transplant recipients, as they can develop S. stercoralis hyperinfection syndrome from proliferative larval production and migration, leading to disseminated disease and the potential for life-threatening bacterial gut translocation [60].…”
Section: Parasitesmentioning
confidence: 99%
“…Infection occurs when humans come into contact with soil that is contaminated with filariform larvae, which then penetrate the skin and enter the lymphatic system. Infection with this organism is particularly dangerous for transplant recipients, as they can develop S. stercoralis hyperinfection syndrome from proliferative larval production and migration, leading to disseminated disease and the potential for life-threatening bacterial gut translocation [60].…”
Section: Parasitesmentioning
confidence: 99%
“…Therefore, infected patients can be considered as suitable recipients. Nevertheless, careful selection of kidney donors and recipients with appropriate antischistosomal treatment for at least one month before transplantation are highly recommended [ 236 , 237 ].…”
Section: Discussionmentioning
confidence: 99%
“…As regards echinococcosis (cystic and alveolar) , transplantation of the involved organ should be regarded as a valuable treatment option. Recurrence inside and/or outside the transplanted organ is possible [ 199 , 200 , 201 , 202 , 203 , 237 ].…”
Section: Discussionmentioning
confidence: 99%
“…Immunocompromised patients are at risk of developing hyperinfection syndrome and disseminated strongyloidiasis that can be fatal, mostly due to Gram-negative bacteremia and sepsis [ 3 , 4 ]. Severe strongyloidiasis typically follows corticosteroid therapy, but has also been described in patients with lymphoma, leukemia, human T-cell lymphotropic virus (HTLV) and HIV infection, malnutrition, chronic renal failure and end-stage renal disease, alcoholism, diabetes mellitus, advanced age, and in solid organ transplant recipients [ 2 , 3 , 4 , 5 , 6 , 7 , 8 ]. Therefore, it is mandatory to diagnose and treat chronic carriers, in order to prevent the hyperinfection syndrome if immunosuppressive treatment is planned [ 3 , 4 , 5 , 6 , 7 , 8 ].…”
Section: Discussionmentioning
confidence: 99%